Skip to main content
. 2020 May 1;2020(5):CD008649. doi: 10.1002/14651858.CD008649.pub4

5.2. Analysis.

5.2

Comparison 5: Mannitol plus dornase alfa versus dornase alfa ‐ cross‐over study of individuals with cystic fibrosis, Outcome 2: FVC (% change from baseline)